Menu

Adrien ROUX

LAUSANNE

En résumé

Adrien ROUX :

Travaille depuis 2001 dans la recherche dans le domaine public (CNRS, Institut Curie, HEPIA) et dans le privé du diagnostic ou du pharmaceutique (Cezanne, Merck-Serono).

Mes compétences :
Recherche et Développement
Recherche
Biochimie
Biotechnologie
Biologie
Gestion de projet
Qualité

Entreprises

  • Merck Serono, Geneva (Switzerland)

    maintenant

  • Tissue Engineering Laboratory at HEPIA – HES (Geneva School of Engineering) - Scientist (Consultant) / In-vitro system specialist

    2013 - maintenant Development of human neural tissue spheroids (3D tissue culture system) for toxicological screening. Management of a project on the automation of 3D cell culture, participation and speaker at external conferences. Development of an in intro neurotoxicity platform using immortalized human neural progenitor cell line (2D). Management of students (master student and CFC student).
    www.bio-ingenierie.ch

  • MERCK-SERONO - PhD Student

    Lyon 2009 - 2012 Development of an antibody-based vehicle for delivering therapeutic molecules into the Central Nervous System (phage display, protein production and purification, in vivo experiments, molecular biology, biochemistry, cell culture, cellular assay, histology and imaging)
    www.merckserono.com

  • MERCK-SERONO - Student in Cellular Receptors Biology

    Lyon 2008 - 2008 Main Tasks:
    At the cross road of both Chemistry and Biology departments, the Lead Discovery Technology Department (LDT) is responsible for the delivery of drug candidates to the therapeutic areas of Neurology, AutoImmunity, Inflammation and Dermatology (NAIID).

    Purpose of the Role:
    Participate in the department specific goal which is to develop molecular and cellular assays that are then used to support Lead identification efficiently as well as to determine the molecular and cellular modes of action of molecules exhibiting high potency.

    Main Tasks & Responsibilities:
    Explore the mode of action of small molecules signaling through cell receptors.
    Study receptor fate in intact cells by a dual proteomics/cell-imaging approach, given the importance of the receptors homeostasis following their activation by highly potent agonists among which some molecules are expected to be the next generation of drug candidates.

    www.merckserono.com

  • CEZANNE - Technicien Supérieur R&D

    2003 - 2008 La société : immuno-diagnostic médical
    www.cezanne.fr

    Missions :
    Mise au point de l'activité Electrophorèse bi-dimentionnelle
    Recherche de nouveaux marqueurs sériques
    Développement d'un immunodosage utilisant la technologie TRACE (basée sur le FRET)

  • Faculté de médecine de l'Université Paris XII - Technicien R&D

    2002 - 2002 Recherche de nouveaux marqueurs en immuno-histochimie au sein du service d'anatomo-pathologie

  • Institut Curie - Assistant Ingénieur R&D

    PARIS 5 2002 - 2002 Etude des Cadhérines à l'échelle unimoléculaire
    Techniques utilisées : Biologie moléculaire (PCR, Clonage), Culture cellulaire, purification protéique, chambre de flux, SDS-PAGE, Western-Blot,...

    www.curie.fr

  • Faculté de pharmacie de Paris - Technicien R&D

    2001 - 2001 Etude de la glycation du collagène due au diabète (technique biochimique)

Formations

  • Université De Genève (Genève)

    Genève 2009 - maintenant International PhD program in Basic and Applied Molecular Life Sciences

    http://lifesciencesphd.unige.ch/
    PhD in Basic and Applied Molecular Life Sciences

  • Université Nîmes

    Nîmes 2006 - 2008 option Génie Biomédical et Pharmaceutique

    www.unimes.fr

  • Conservatoire National Des Arts Et Métiers

    Paris 2001 - 2005 Chaire de biologie

    www.cnam.fr

  • Université Paris 12 Val De Marne (Creteil)

    Creteil 1999 - 2001 Génie Biologique option Analyse Biologique et Biochimique

    www.iut.univ-paris12.fr

  • Lycée Maurice Ravel (Paris)

    Paris 1995 - 1999 Scientifique (option Biologie)

    http://www.lycee-maurice-ravel.fr

Réseau

Annuaire des membres :